We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Harnessing AI to Improve Drug Combination Design

News   Sep 26, 2018 | Original story from SLAS

 
Harnessing AI to Improve Drug Combination Design

Harnessing Artificial Intelligence to Improve Drug Combination Design and Personalized Medicine. Credit: Zac Goh

 
 
Advertisement
 

RELATED ARTICLES

Anti-parasitic Drug Eliminates SARS-CoV-2 Within 48 Hours in Cell Culture

News

A Monash University-led study has shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours in cell culture.

READ MORE

Genetic Variations in the Skin Can Create a Natural Sunscreen

News

Genetic variations in the skin can create a natural sunscreen, according to Queensland Brain Institute researchers investigating the genes linked with vitamin D.

READ MORE

Treating COVID-19 in a Patient With Multiple Myeloma – A Case Study

News

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective therapeutic strategy against COVID-19 in infected patients who also have multiple myeloma and other blood cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE